Pharmaceutical press releases & news - Bristol Myers Squibb
5 days ago · Explore Bristol Myers Squibb's latest press releases to learn more about our company, our medicines and research innovation, our partnerships, our people, and our Foundation efforts as we work to support patients fighting serious disease.
Bristol Myers Faces Renewed, $6.7 Billion Lawsuit Over Delayed …
Nov 14, 2024 · NEW YORK (Reuters) - Bristol Myers Squibb was hit on Thursday with a $6.7 billion lawsuit claiming it cheated former Celgene shareholders by delaying federal approval for three drugs, 1-1/2...
Bristol Myers faces renewed, $6.7 bln lawsuit over delayed cancer …
Nov 14, 2024 · Bristol Myers Squibb was hit on Thursday with a $6.7 billion lawsuit claiming it cheated former Celgene shareholders by delaying federal approval for three drugs, 1-1/2 months after a...
Bristol Myers Squibb - Press Releases
Receive updated news from preferred websites, which are sent directly to the user's news reader. This includes the headlines, summaries and links to the full article on the website.
Bristol Myers Squibb - Bristol Myers Squibb Completes …
Mar 18, 2024 · PRINCETON, N.J.-- (BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) today announced that it has successfully completed its acquisition of Karuna Therapeutics, Inc. (“Karuna”).
News and media - Bristol Myers Squibb
Visit the Bristol Myers Squibb newsroom & stay up to date with our most current news as we continue to make a difference in the lives of our patients.
Bristol Myers Squibb - Bristol Myers Squibb Completes …
Jan 23, 2024 · PRINCETON, N.J.-- (BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) today announced that it has successfully completed its acquisition of Mirati Therapeutics, Inc. ® (“Mirati”).
Truist Financial Remains a Buy on Bristol-Myers Squibb (BMY)
14 hours ago · Based on Bristol-Myers Squibb’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $11.89 billion and a net profit of $1.21 billion.
BMS plans $1.5B in cuts through '25, with 2,000-plus layoffs
Apr 25, 2024 · Bristol Myers Squibb is the latest large pharma to wield the restructuring ax, with plans to cut $1.5 billion in costs by the end of 2025, including laying off more than 2,000 employees.
Bristol Myers Squibb (BMY) Stock Declines While Market …
4 days ago · The latest trading session saw Bristol Myers Squibb (BMY) ending at $56.59, denoting a -0.35% adjustment from its last day's close. The stock's performance was behind the S&P 500's daily gain of 1 ...